CD BioGlyco provides comprehensive Glycosylation Inhibitor Development services to our clients, including UDP-glucose inhibitor development services. We use the latest chemical screening and drug design techniques, structure optimization, and dosimetry according to client needs, and we perform product activity validation through rigorous experiments. Our UDP-glucose inhibitor development services include but are not limited to:
Fig.1 How do we approach the development of UDP-glucose inhibitors? (CD BioGlyco)
Fig.2 The functions and synthesis of UDP-Glc in plants. (Lazarowski & Harden, 2015)
The development of UDP-glucose small molecule inhibitors is an area of specialization that requires a great deal of experience, despite the large amount of published research in the field. CD BioGlyco offers best-in-class chemistry solutions for your UDP-glucose inhibitors development. If you need any further information, please don't hesitate to contact us.